Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
Key Details
- 1scSurvival is a machine learning model designed for single-cell resolution analysis in cancer assessment.
- 2Developed with NIH funding by Oregon Health & Science University researchers.
- 3Tested on data from over 150 cancer patients, the tool linked specific tumor and immune cell populations to varying risk and survival outcomes.
- 4The model outperformed traditional methods in predicting outcomes in melanoma and liver cancer.
- 5Research appeared in the journal Cancer Discovery on April 21, 2026.
Why It Matters
Single-cell analytics and AI are at the cutting edge of precision oncology, offering deeper insight into tumor heterogeneity and treatment response. These advances may significantly enhance radiology's role in prognostication and personalized care, especially as multi-modal data integration becomes more common.
Source
EurekAlert
Related News
•EurekAlert
FDA Approves Johns Hopkins AI Tool for Early Sepsis Detection
FDA clears an AI-driven system developed by Johns Hopkins to detect sepsis up to 48 hours earlier and reduce mortality rates.
•EurekAlert
New AI Vision-Language Model Enhances Chest CT Diagnostics
Researchers developed an interpretable AI model that uses visual question answering to generate detailed diagnostic findings from chest CT scans, aimed at improving lung cancer diagnosis.
•EurekAlert
Optical AI Chip Boosts Real-Time Dry Eye Gland Diagnosis Accuracy
A new metasurface spectral AI chip enables rapid, accurate diagnosis of meibomian gland dysfunction (MGD) from tissue samples, achieving 96.22% accuracy.